Hongsheng Wu

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Comparative Effectiveness of Allopurinol and Febuxostat in Gout Management”.

Comparative Effectiveness of Allopurinol and Febuxostat in Gout Management

NEJM Evidence(2022)10.1056/evidoa2100028

N/A

2.3DataRank · unranked

102 citations

Mary T. Brophy, Michael H. Pillinger, Tuhina Neogi, Paul M. Palevsky, Hongsheng Wu +12 more

Safety testing of Ovaprene: An investigational nonhormonal monthly vaginal contraceptive

Contraception(2024)10.1016/j.contraception.2024.110440

N/A

0.172DataRank · unranked

2 citations

Andrea R. Thurman, Jeffrey T. Jensen, Courtney A. Schreiber, Jeff Baker, Melody Y. Hou +11 more

Comparison of Gout Flares With the Initiation of Treat‐to‐Target Allopurinol and Febuxostat: A Post‐Hoc Analysis of a Randomized Multicenter Trial

Arthritis & Rheumatology(2024)10.1002/art.42927

N/A

0DataRank · unranked

10 citations

Lindsay N. Helget, Maria Androsenko, Hongsheng Wu, Bridget Kramer, Jeff A. Newcomb +11 more

Menstrual cup use and intrauterine device expulsion in a copper intrauterine device randomized trial

Contraception(2024)10.1016/j.contraception.2024.110415

N/A

0DataRank · unranked

6 citations

Mitchell D. Creinin, Hongsheng Wu, David Hubacher, Courtney A. Schreiber, Bliss Kaneshiro +3 more

Successful postcoital testing of Ovaprene: An investigational non-hormonal monthly vaginal contraceptive

Contraception(2024)10.1016/j.contraception.2024.110373

N/A

0DataRank · unranked

5 citations

Andrea R. Thurman, Jeffrey T. Jensen, Courtney A. Schreiber, Jeff Baker, Melody Y. Hou +7 more

Improvements in Health‐Related Quality of Life With Treat‐to‐Target Urate‐Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial

Arthritis Care & Research(2025)10.1002/acr.25618

N/A

0DataRank · unranked

3 citations

Bryant R. England, Harlan Sayles, Lindsay N. Helget, Maria Androsenko, Hongsheng Wu +12 more

Real-world persistence of urate-lowering therapy following a treat-to-target intervention: A two-year follow-up analysis of the STOP gout trial

Seminars in Arthritis and Rheumatism(2025)10.1016/j.semarthrit.2025.152800

N/A

0DataRank · unranked

1 citations

Harlan Sayles, Lindsay N. Helget, Bryant R. England, Punyasha Roul, Jeff A. Newcomb +11 more

The Epidemiologic Comparison of Two Correlated Relative Risks: A Simple but Efficient Clinical Trial Design for Assessing Risk-Reduction and Treatment Significance

Medicina(2025)10.3390/medicina62010070

N/A

0DataRank · unranked

0 citations

Genevieve Dupuis, Yuk Ming Choi, Hongsheng Wu, Jimmy T. Efird

Determinants of Achieving Serum Urate Goal with Treat‐to‐Target Urate‐Lowering Therapy in Gout

Arthritis & Rheumatology(2023)10.1002/art.42731

N/A

0DataRank · unranked

21 citations

James R. O’Dell, Jeff A. Newcomb, Maria Androsenko, Mary T. Brophy, Anne Davis‐Karim +9 more